LifeMD (NASDAQ: LFMD) CEO Justin Schreiber: “LifeMD’s Growth and Acceleration Show No Signs of Slowing”
“..Our first quarter of 2021 was not only marked by record topline performance, it also saw us make significant strides in solidifying the infrastructure, which will enable LifeMD to scale efficiently towards longer term profitability....As an industry leader in telehealth customer acquisition, our growth potential remains massive. We are operating in open whitespace of a nascent industry with a total addressable market of nearly a trillion dollars.“
“...We have built a platform that has the ability to support tens if not hundreds of direct to patient telemedicine offerings and seeing the value of our offerings, our patients are overwhelmingly choosing subscription based products and services, which have been fueling our significant sequential growth…..In the last week of the quarter, we launched Nava MD, a direct to patient clinical tele-dermatology services brand for women, which added further diversification to our growing portfolio of companies. Nava MD is our third launch in four years, and we look forward to further developing the brand. In addition, as I've spoken about before, we continue to anticipate launching our namesake LifeMD primary care platform later this summer. We believe this launch, coupled with our very successful current and future conditions specific telemedicine brands will provide LifeMD with a powerful and differentiated end-to-end direct to patient telehealth platform…”
LifeMD (NASDAQ: LFMD) Earnings Highlights: https://bit.ly/2V1FNjL
WALL STREET REPORTER
Wall Street Reporter (Est. 1843) is the leading financial news provider, focused on giving investors direct access to CEO's of promising, publicly-traded companies, and market experts. www.WallStreetReporter.com. Nothing in this news summary shall be construed as investment advice. Quotes/content may be edited for brevity and context. Full disclaimer, and relevant SEC 17B disclosures here: http://bit.ly/39kkE7K
About Wall Street Reporter’s Next Super Stock conference:
Wall Street Reporter's NEXT SUPER STOCK Live! conference is dedicated to featuring select companies that have near-term catalysts in place which can drive transformational growth (and stock appreciation) in the months ahead. Click here to join next livestream event: https://www.wallstreetreporter.com/next-superstock-online-investor-conference/
CONTACT:
WALL STREET REPORTER
(212) 871-2057 ext 7
www.WallStreetReporter.com
___________________________________________________________________
*** Yes, its time to make money ***
Recent LFMD News
- LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock • GlobeNewswire Inc. • 03/26/2024 12:00:00 PM
- LifeMD to Participate in the 23rd Annual Needham Virtual Healthcare Conference • GlobeNewswire Inc. • 03/25/2024 12:00:00 PM
- LifeMD Reports Fourth Quarter 2023 Results • GlobeNewswire Inc. • 03/11/2024 08:05:00 PM
- U.S. Index Futures Dip Ahead of Inflation Data and Oracle’s Earnings; Oil Prices Edge Higher • IH Market News • 03/11/2024 10:39:47 AM
- LifeMD to Report Fourth Quarter 2023 Financial Results on March 11 • GlobeNewswire Inc. • 02/26/2024 01:00:00 PM
- LifeMD to Participate in Upcoming Investor Conferences and Webinar • GlobeNewswire Inc. • 02/15/2024 01:00:00 PM
- LifeMD to Participate in the 11th Annual BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference • GlobeNewswire Inc. • 01/31/2024 01:00:00 PM
- Maxim Group LLC to Host the 2024 Healthcare IT Virtual Conference on Wednesday, January 24th & Thursday, January 25th at 9:00 A.M. ET • GlobeNewswire Inc. • 01/22/2024 09:15:00 PM
- LifeMD to Participate in the Maxim Group 2024 Healthcare IT Virtual Conference • GlobeNewswire Inc. • 01/18/2024 01:00:00 PM
- LifeMD Provides 2024 Financial Guidance • GlobeNewswire Inc. • 01/08/2024 01:00:00 PM
- WeightWatchers Stock Drops 12% After Eli Lilly Launches DTC Weight-Loss Drug Service • Dow Jones News • 01/04/2024 09:30:00 PM
- LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock • GlobeNewswire Inc. • 12/26/2023 09:05:00 PM
- LifeMD and Medifast Partner to Offer Transformative Weight Management Solution • GlobeNewswire Inc. • 12/13/2023 11:00:00 AM
- LifeMD Executives to Participate in RWJBarnabas Health’s Telehealth Symposium • GlobeNewswire Inc. • 12/07/2023 01:00:00 PM
- LifeMD to Participate in Upcoming Investor Conferences and Panel Discussions • GlobeNewswire Inc. • 11/10/2023 01:00:00 PM
- LifeMD Reports Third Quarter 2023 Results; Record Revenue and Adjusted EBITDA • GlobeNewswire Inc. • 11/08/2023 09:05:00 PM
- LifeMD Ranked Number 166 Fastest-Growing Company in North America on the 2023 Deloitte Technology Fast 500™ • GlobeNewswire Inc. • 11/08/2023 01:00:00 PM
- LifeMD to Report Third Quarter 2023 Financial Results on November 8 • GlobeNewswire Inc. • 10/25/2023 12:00:00 PM
- Particle Health and LifeMD Demonstrate the Potential of Using Comprehensive Electronic Health Record Data to Triage Patients for GLP-1 Weight Management Therapy • GlobeNewswire Inc. • 10/03/2023 10:00:00 AM
- LifeMD to Participate in Two Investor Conferences in October • GlobeNewswire Inc. • 09/27/2023 12:00:00 PM
- LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock • GlobeNewswire Inc. • 09/26/2023 12:00:00 PM
- LifeMD and ASCEND Therapeutics Launch Integrated Direct-to-Consumer Telehealth Model for Hormone Therapy • GlobeNewswire Inc. • 09/21/2023 10:00:00 AM
- LifeMD to Participate in Two Investor Conferences in September • GlobeNewswire Inc. • 08/30/2023 12:00:00 PM
- LifeMD Reports Second Quarter 2023 Results; Achieves Positive Free Cash Flow and Raises 2023 Revenue Guidance • GlobeNewswire Inc. • 08/09/2023 08:05:00 PM
- LifeMD to Present at Sidoti’s Micro-Cap Virtual Conference • GlobeNewswire Inc. • 08/02/2023 12:00:00 PM
VPR Brands LP Reports Record Annual Financial Performance for Fiscal Year 2023 • VPRB • Apr 19, 2024 11:24 AM
Coinllectibles' Subsidiary, Grand Town Development Limited, Acquires Rare Song Dynasty Ceramics Worth Over USD28million • COSG • Apr 18, 2024 8:03 AM
ILUS Provides Form 10-K Filing Update • ILUS • Apr 17, 2024 9:54 AM
Glucotrack Announces Expansion of Its Continuous Glucose Monitoring Technology to Epidural Glucose Monitoring • GCTK • Apr 17, 2024 8:00 AM
Maybacks Global Entertainment To Fire Up 24 New Stations in Louisiana • AHRO • Apr 16, 2024 1:30 PM
Cannabix Technologies Begins Certification of Contactless Alcohol Breathalyzer, Re-Brands product series to Breath Logix • BLOZF • Apr 16, 2024 8:52 AM